News
CNBI
0.0002
NaN%
--
Weekly Report: what happened at CNBI last week (0414-0418)?
Weekly Report · 4d ago
Weekly Report: what happened at CNBI last week (0407-0411)?
Weekly Report · 04/14 10:09
Weekly Report: what happened at CNBI last week (0331-0404)?
Weekly Report · 04/07 10:09
Weekly Report: what happened at CNBI last week (0324-0328)?
Weekly Report · 03/31 10:15
Weekly Report: what happened at CNBI last week (0317-0321)?
Weekly Report · 03/24 10:09
Weekly Report: what happened at CNBI last week (0310-0314)?
Weekly Report · 03/17 10:14
Weekly Report: what happened at CNBI last week (0303-0307)?
Weekly Report · 03/10 10:15
Weekly Report: what happened at CNBI last week (0224-0228)?
Weekly Report · 03/03 10:15
Weekly Report: what happened at CNBI last week (0217-0221)?
Weekly Report · 02/24 10:15
Weekly Report: what happened at CNBI last week (0210-0214)?
Weekly Report · 02/17 10:13
Weekly Report: what happened at CNBI last week (0203-0207)?
Weekly Report · 02/10 10:10
Weekly Report: what happened at CNBI last week (0127-0131)?
Weekly Report · 02/03 10:12
Weekly Report: what happened at CNBI last week (0120-0124)?
Weekly Report · 01/27 10:14
Weekly Report: what happened at CNBI last week (0113-0117)?
Weekly Report · 01/20 10:10
Weekly Report: what happened at CNBI last week (0106-0110)?
Weekly Report · 01/13 10:10
Weekly Report: what happened at CNBI last week (1230-0103)?
Weekly Report · 01/06 10:15
Weekly Report: what happened at CNBI last week (1223-1227)?
Weekly Report · 12/30/2024 10:11
Weekly Report: what happened at CNBI last week (1216-1220)?
Weekly Report · 12/23/2024 10:15
Weekly Report: what happened at CNBI last week (1209-1213)?
Weekly Report · 12/16/2024 10:16
Weekly Report: what happened at CNBI last week (1202-1206)?
Weekly Report · 12/09/2024 10:14
More
Webull provides a variety of real-time CNBI stock news. You can receive the latest news about China Bct Pharma through multiple platforms. This information may help you make smarter investment decisions.
About CNBI
China BCT Pharmacy Group Inc is a holding company primarily engaged in the pharmaceutical distribution. The Company mainly operates it business through three segments. The Pharmaceutical Distribution segment is engaged in the purchasing pharmaceutical products from suppliers and then distributing them to wholesale customers, including hospitals, retail drug stores, other pharmaceutical wholesalers, clinics, medical centers, and individuals. The Retail Pharmacy segment is engaged in the operation of retail drug stores under the registered name Baicaotang. The Manufacturing segment is engaged in the production and sales of pharmaceutical products under the registered name Asio including traditional anti-inflammatory and antibacterial drugs, cancer treatment drugs, cardio-vascular disease drugs and hepatitis drugs. The Company mainly conducts its business in the domestic market.